Temporal and spatial patterns of pathological changes such as loss of neurons and presence of pathological protein aggregates are characteristic of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Alzheimer's disease and Parkinson's disease. These patterns are consistent with the propagation of protein misfolding and aggregation reminiscent of the prion diseases. There is a surge of evidence that suggests that large protein aggregates of a range of proteins are able to enter cells via macropinocytosis. Our recent work suggests that this process is activated by the binding of aggregates to the neuron cell surface. The current review considers the potential role of cell surface receptors in the triggering of macropinocytosis by protein aggregates and the possibility of utilizing macropinocytosis pathways as a therapeutic target. 
Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS),
Frontotemporal Dementia (FTD), Alzheimer's disease, and Parkinson's disease have temporal and spatial patterns of pathological changes such as loss of neurons and presence of pathological protein aggregates [1] [2] [3] [4] . The patterns that have been identified in neuropathological studies are have been suggested to be consistent with propagation of protein misfolding and aggregation reminiscent of the prion diseases 5 .
Evidence from in vitro studies suggests that large protein aggregates of a range of proteins (SOD1, tau, α-synuclein, and proteins containing expanded polyglutamine repeats) are able to enter cells via an incompletely understood mechanism and propagate misfolding and aggregation [6] [7] [8] [9] [10] [11] [12] [13] [14] . Animal studies demonstrate that injection of brain or spinal cord extracts from transgenic mice expressing human tau, SOD1 or α-synuclein can seed pathology in transgenic mice at the sites of injection and initiate spread of pathology to other regions of the nervous system [14] [15] [16] [17] . These data combined with the patterns of neurodegeneration provide strong evidence of prion-like protein misfolding propagation in neurodegenerative diseases such as Parkinson's disease and
ALS. The precise mechanism of cell-to-cell propagation of protein misfolding in vivo remains unclear. There are several possible scenarios that may explain the propagation of protein misfolding, the most commonly proposed of which is the release of protein aggregates in to the extracellular space and subsequent uptake in to nearby or connected naïve neurons where seeding can then take place. In this model both aggregate release and subsequent uptake are requisite. Misfolded or aggregated material may be released from cells via an active mechanism, either within exosomes or naked, or alternatively, aggregates may be passively released from dead or dying cells. In reality, within a complex biological system it is likely that the release of aggregated protein may be a combination of each of the possible release mechanisms.
This makes therapeutic targeting of aggregate release difficult, moreover, reducing the burden of misfolded protein by active release may be beneficial to the cell and thus its blockade detrimental. One aspect of protein misfolding propagation that may provide a more tractable therapeutic target is the entry of protein aggregates in to cells.
Work to date suggests that macropinocytosis may be responsible for the uptake of protein aggregates associated with various neurodegenerative diseases 6, 11, [18] [19] [20] [21] 27 . As a result, further work is required to more precisely define the precise mode of endocytosis responsible for protein aggregate uptake.
Macropinocytosis is a type of endocytosis that is partly defined by pinosome size, macropinosomes can be several micron in diameter. Macropinocytosis can be constitutive or a transient process, generally triggered by growth factors but has been observed to be activated by particles such as bacteria, apoptotic bodies and viruses 28 .
Its activation leads to formation of large membrane ruffles that can fold back on the cell allowing the internalisation of fluid, membrane and other particles into large vacuoles several micron in diameter 29 . The role of stimulation of macropinocytosis in aggregate uptake remains unclear.
Our recent work shows that SOD1 aggregates can bind to the cell surface and trigger activation of membrane ruffling in NSC-34 cells and iPSC generated human neurons 21 consistent with stimulated rather than constitutive macropinocytosis. The engulfment of aggregates in to macropinosomes could explain the ease by which aggregates enter the cytosol. Macropinosomes are considered 'leaky' due to their lack of physical structure compared with coated vesicles 30 Neurons express heparan sulfate proteoglycans 51 , RAGE 52 , CD36 53 , integrins 33 and receptor tyrosine kinases such as EphA2 and EphA4 54 . This is consistent with neurons having all the machinery to bind aggregates and to trigger macropinocytosis with a receptor complex similar to that involved in viral uptake and somewhat similar to that of microglial cell surface recognition ( Figure 1C ). Indeed, a macropinocytosis-like process regulates growth cone membrane recycling, growth cone collapse, axon retraction and turning during development and injury [55] [56] [57] [58] [59] . Future work will be needed to further characterise the composition of the neuron specific set of cell surface proteins that are responsible for the binding, triggering of macropinocytosis and uptake of protein aggregates. Given that blocking all macropinocytosis in the brain, including microglial and astrocytic, may be detrimental this knowledge could be used was found to inversely correlate with disease onset and survival, and loss-of-function mutations in EPHA4 were found to be associated with slower disease progression and longer survival 60 . It is tempting to speculate that EphA4 might contribute to the activation of macropinocytosis and uptake of protein aggregates, which might be slowed in its absence or inhibition. Identifying such a target that will supress the neuronal macropinocytosis of protein aggregates but will allow the microglial phagocytosis and degradation of such particles is vital. Blocking all endocytosis of aggregates may be detrimental.
In summary, propagation of protein misfolding and aggregation is implicated in the progressive nature of several neurodegenerative diseases such as Alzheimer's disease,
Parkinson's disease and ALS. In order for propagation to proceed aggregates must be able to gain access to the cytosol of naïve neurons and current evidence suggests that stimulated macropinocytosis is responsible for this uptake. The receptor complexes responsible for this are still to be defined, but this information may provide therapeutic targets that could halt or slow the spread of pathology. 
